Blood test could replace kidney biopsy for common kidney disease?

NCT ID NCT07295808

Recruiting now Knowledge-focused Sponsor: University Hospital, Limoges Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at blood and kidney tissue from 150 adults with IgA nephropathy or related kidney diseases. Researchers want to find unique patterns in immune cells that cause kidney damage. The goal is to develop a blood test that could diagnose the disease without a painful kidney biopsy.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could lead to a simple blood test to diagnose IgA nephropathy, reducing the need for invasive kidney biopsies.
What could go wrong: This is an early observational study, not a treatment trial. It may not find reliable markers, and any future test would require much more research.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for IGA VASCULITIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

IgA glomerulonephritis immunoglobulin A vasculitis impaired renal function disease kidney disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

KIDNEY DISEASE

Contacts and locations

Locations

Chu Limoges
RECRUITING

Limoges, 87042, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.